UK startup hopes FDA nod speeds up adoption of VR therapy
The breakthrough device designation for Oxford VR follows a clinical trial that demonstrated the effectiveness of its VR therapy.
The breakthrough device designation for Oxford VR follows a clinical trial that demonstrated the effectiveness of its VR therapy.
The company's vaccine is the second approved for emergency use by the FDA. It is expected to pose fewer logistical challenges than the first, which was developed by Pfizer and BioNTech.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Founded in 2009, Medial EarlySign is making use of artificial intelligence technology and EHR data to predict which individuals are at risk for specific health conditions.
I remember being in elementary and middle school and girls started talking about who had started their periods yet and who hadn’t. In fact, starting your period had some sort of cool-factor to it, and I’m pretty sure a girl I knew in 6th grade lied about starting hers before it actually happened to gain […]